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Effects of propofol on the 
inflammatory response during 
robot-assisted laparoscopic radical 
prostatectomy: a prospective 
randomized controlled study
Go Un Roh1, Young Song2,3, Junbeom Park1, Yu Min Ki1 & Dong Woo Han2,3
Robot-assisted laparoscopic radical prostatectomy (RALRP) is a minimally invasive procedure; 
however, some amount of surgical trauma that can trigger systemic inflammation remains. Moreover, 
pneumoperitoneum during RALRP induces ischemia–reperfusion injury (IRI). Propofol, an anesthetic, 
is known to have anti-inflammatory and antioxidant properties. In the present study, we compared the 
effects of propofol with those of desflurane on inflammation and IRI during RALRP via measurements 
of different biomarkers and evaluation of perioperative renal function. Fifty patients were randomized 
to receive either desflurane (n = 25) or propofol (n = 25) with remifentanil during RALRP. Serum 
levels of interleukin (IL)-6 (IL-6), tumor necrosis factor alpha, C-reactive protein, and nitric oxide were 
measured 10 min after anesthesia induction (T1), 100 min after carbon dioxide (CO2) insufflation (T2), 
and 10 min after CO2 deflation (T3). Perioperative urine outputs and the serum creatinine level at 24 h 
after surgery were also recorded. We found that IL-6 levels at T2 and T3 were higher than those at T1 in 
both groups, although the increases were significant attenuated only in the propofol group. The other 
parameters showed no differences among the three time points in both groups. The intraoperative urine 
output was significantly higher in the propofol group than in the desflurane group, while the creatinine 
level showed no significant changes in either group. Our findings suggest that propofol can not only 
attenuate the inflammatory response during and after pneumoperitoneum in patients undergoing 
RALRP but also prevent oliguria during pneumoperitoneum.
Prostate cancer is currently the most common malignancy in men and the second leading cause of cancer-related 
death in the West. Over the last decade, minimally invasive radical prostatectomy with robot-assisted laparoscopy 
has gained popularity for the treatment of prostate cancer1,2. Compared with conventional, more invasive pro-
cedures, laparoscopic surgery allows for a smaller abdominal incision and causes less tissue trauma along with a 
reduced stress response. However, such minimally invasive procedures require pneumoperitoneum for adequate 
visualization and surgical manipulation, and the associated insufflation and deflation procedures often lead to 
ischemia–reperfusion injury (IRI) and exacerbate inflammation and the oxidative stress response, consequently 
leading to postoperative complications3–5. Although several studies have attempted to minimize inflammation 
and IRI during laparoscopic surgery, none have reported clinically promising results6,7.
Propofol, a popular intravenous agent for the induction and maintenance of anesthesia, is known to have 
anti-inflammatory and antioxidant effects8–10. Previous studies have demonstrated that propofol reduces lipid 
peroxidation and proinflammatory cytokine levels after myocardial ischemia reperfusion11. In a previous study 
involving craniotomy, propofol was associated with significantly higher anti-inflammatory cytokine levels 
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than was the volatile anesthetic12. Furthermore, in an animal model of renal IRI, propofol attenuated oxida-
tive renal damage and accelerated recovery after IRI13. On the other hand, desflurane, a common volatile anes-
thetic, has shown somewhat conflicting results concerning its anti-inflammatory effects. In a mouse model of 
ventilator-induced lung injury, desflurane did not prevent inflammatory responses and production of reactive 
oxygen species14. Another study found that the increase in inflammatory cytokine levels was lesser with desflu-
rane anesthesia than with propofol anesthesia during coronary artery bypass grafting15. However, to our knowl-
edge, no study has evaluated and compared the preventive effects of propofol and desflurane against inflammation 
and IRI in human patients undergoing robot-assisted laparoscopic surgery.
Therefore, in the present study, we compared the effects of propofol with those of desflurane on inflammation 
and IRI during robot-assisted laparoscopic radical prostatectomy (RALRP) via measurements of different bio-
markers and evaluation of perioperative renal function.
Results
All 50 patients completed the study. There were no significant differences in patient characteristics between the 
propofol and desflurane groups (Fig. 1). Although the number of patients with diabetes mellitus was higher in the 
propofol group, the difference was not statistically significant (Table 1). The durations of anesthesia, surgery, and 
pneumoperitoneum were similar between the two groups.
Moreover, IL-6 levels at 10 min after induction (T1) were similar between the two groups. Within groups, IL-6 
levels at T2 (p < 0.001) and T3 (p < 0.001) were significantly higher than the level at T1, while intergroup compar-
isons showed that IL-6 levels at T2 (1.52 ± 0.96 pg/mL vs. 3.72 ± 2.30 pg/mL; p < 0.001) and T3 (4.68 ± 2.76 pg/
mL vs. 8.57 ± 3.72 pg/mL; p < 0.001) were significantly lower in the propofol group than in the desflurane group. 
There were no significant differences in TNF-α, CRP, and NO levels at any time point between the two groups 
(Fig. 2). The intraoperative urine output was significantly higher in the propofol group (440 ± 235 ml) than in 
the desflurane group (299 ± 208 ml; p = 0.031), although there were no differences in the amount of fluid intake 
and intraoperative bleeding. The remifentanil dose was greater in the propofol group (1161 ± 430 mcg) than in 
the desflurane group (1104 ± 515 mcg; p = 0.001), with no differences in the duration of infusion (Table 2). The 
heart rate was consistently lower in the propofol group during surgery. The mean arterial pressure (MAP) was 
comparable between groups at all time points except 10 min after anesthesia induction (77.8 ± 12.3 vs. 68.5 ± 9.3; 
p = 0.004; Fig. 3). The frequency of hypotension and the required dose of ephedrine were both higher in the des-
flurane group than in the propofol group (Table 3).
The postoperative urine output was similar between the two groups until the third postoperative day. 
Postoperative serum creatinine levels exhibited a similar and clinically insignificant decrease in both groups 
(Table 3). No patient experienced any surgical or clinical complication, and all were discharged from the hospital 
in accordance with the guidelines established for their respective surgical procedures.
Figure 1. CONSORT diagram showing the participant recruitment process. In total, 50 patients were 
randomized to receive desflurane (n = 25) or propofol (n = 25) anesthesia during radical robot-assisted 
laparoscopic radical prostatectomy (RALRP), and all 50 patients completed the study.
3Scientific RepoRts |          (2019) 9:5242  | https://doi.org/10.1038/s41598-019-41708-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
Discussion
In the present study, we observed that propofol anesthesia significantly attenuated the increase in IL-6 levels dur-
ing RALRP, unlike desflurane anesthesia. However, both propofol and desflurane had similar effects on TNF-α, 
CRP, and NO levels. The intraoperative urine output was significantly greater in the propofol group, although 




(n = 25) p-value
Age (years) 61.7 ± 5.4 63.8 ± 5.0 0.173
Height (cm) 167.8 ± 5.8 168.0 ± 6.1 0.925
Weight (kg) 69.5 ± 6.9 70.0 ± 7.5 0.891
Medical history
   Hypertension 11 (44) 15 (60) 0.258
   Diabetes mellitus 6 (24) 1 (4) 0.098
Preoperative medication
   Angiotensin receptor blocker 6 (24) 7 (28) 0.747
   Diuretics 2 (8) 3 (12) 1.000
Table 1. Characteristics of patients who received propofol or desflurane anesthesia during robot-assisted 
laparoscopic radical prostatectomy.
Figure 2. Perioperative changes in interleukin (IL)-6 (a), tumor necrosis factor alpha (TNF-α) (b), C-reactive 
protein (CRP) (c), and nitric oxide (NO) (d) levels in patients who received propofol (n = 25) or desflurane 
(n = 25) anesthesia during robot-assisted laparoscopic radical prostatectomy (RALRP). T1, 10 min after 
anesthesia induction; T2, 100 min after pneumoperitoneum; T3, 10 min after carbon dioxide deflation. 
*p < 0.001 for intergroup comparisons. †p < 0.001 vs. T1.
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Compared with conventional open surgery, laparoscopic surgery is associated with smaller incisions, 
reduced intraoperative bleeding, and lesser postoperative pain; however, it may result in increased trauma due 




(n = 25) p-value
Duration of anesthesia (min) 246.8 ± 34.1 242.4 ± 33.4 0.653
Duration of surgery (min) 186.5 ± 32.1 186.0 ± 33.4 0.962
Duration of pneumoperitoneum (min) 147.5 ± 26.9 144.6 ± 25.7 0.697
Fluid intake (mL) 1882.0 ± 483.0 1848.0 ± 619.9 0.830
Bleeding (mL) 329.6 ± 224.0 277.2 ± 191.9 0.379
Urine output (mL) 440.3 ± 234.6 299.0 ± 207.8 0.031
Remifentanil
   Dose (mcg) 1611.4 ± 430.0 1103.7 ± 515.2 0.001
   Dose (mcg/kg/min) 0.10 ± 0.02 0.07 ± 0.02 <0.001
Ephedrine
   Patients (number) 7 (28) 18 (72) 0.002
   Dose (mg) 2.7 ± 5.1 12.6 ± 11.1 <0.001
Table 2. Intraoperative data for patients who received propofol or desflurane anesthesia during robot-assisted 
laparoscopic radical prostatectomy.
Figure 3. Perioperative hemodynamic changes in the heart rate (a) and mean arterial pressure (b) in patients 
who received propofol (n = 25) or desflurane (n = 25) anesthesia during robot-assisted laparoscopic radical 
prostatectomy (RALRP). T1, 10 min after induction; T2, 100 min after pneumoperitoneum; T3, 10 min after 




(n = 25) p-value
Urine output (mL)
   POD 0 1683.7 ± 425.1 1644.2 ± 395.2 0.752
   POD 1 2100.4 ± 829.1 1997.9 ± 668.3 0.656
   POD 2 2705.2 ± 764.7 2801.4 ± 930.4 0.709
   POD 3 2264.4 ± 605.2 2051.4 ± 682.7 0.279
Serum creatinine (mg/dL)
   Before surgery 0.96 ± 0.16 0.93 ± 0.14 0.544
   POD 1 0.91 ± 0.15 0.83 ± 0.11 0.057
   Difference −0.05 ± 0.12 −0.10 ± 0.12 0.163
Table 3. Perioperative renal profiles for patients who received propofol or desflurane anesthesia during robot-
assisted laparoscopic radical prostatectomy. POD: postoperative day.
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presence of CO2 may further contribute to inflammation and oxidative stress during pneumoperitoneum, which 
result in acute-phase responses such as the release of proinflammatory cytokines and acute-phase proteins16–20. 
Postoperative increases in inflammatory markers, including cytokines and CRP, are associated with tissue dam-
age, postoperative morbidity, and cancer recurrence21–23. However, despite the high number of patients under-
going laparoscopic or robotic surgery, few comparative urology-related studies have investigated inflammation 
induced by surgical tissue damage or pneumoperitoneum-related IRI2,24.
IL-6 is one of the most important ILs that is regulated by both surgery and anesthesia. It is considered the 
most sensitive marker of the inflammatory response to tissue damage2. Among the inflammatory cytokines inves-
tigated in our study, IL-6 was significantly increased after surgery in both groups. This finding suggests that 
IL-6 may represent an appropriate marker of surgical stress in patients undergoing radical prostatectomy for 
prostate cancer, consistent with the findings of several previous studies2,25,26. Because elevated serum IL-6 levels 
are associated with the aggressiveness of prostate cancer and may represent a predictive marker of biochemical 
recurrence after prostatectomy, preoperative evaluation of changes in serum IL-6 levels may be valuable for not 
only surgical stress detection but also prognosis prediction21. Compared with the increases in IL-6 levels in the 
desflurane group, those in the propofol group were significantly attenuated during CO2 insufflation and after the 
termination of pneumoperitoneum in the present study. This result can be attributed to the anti-inflammatory 
properties of propofol, which have been addressed in numerous studies. Clinically relevant concentrations of 
propofol inhibit the functions of neutrophils, which include chemotaxis, phagocytosis, and production of reactive 
oxygen species27. In a model of sepsis involving lipopolysaccharide-activated macrophages, propofol was shown 
to inhibit the production of IL-6 by macrophages by 83%10. Furthermore, in clinical settings, propofol signifi-
cantly lowers IL-6 production following reperfusion during cardiopulmonary bypass28,29. Similarly, in a study 
comparing propofol and sevoflurane anesthesia, the former significantly decreased neutrophil infiltration and 
systemic inflammation during aortic surgery23.
Although the mechanism underlying these effects remains unclear, several reports have suggested that they 
may be associated with intracellular calcium signaling. According to a report by Tang et al., propofol promotes 
the expression of annexin A1 (a membrane calcium protein), which negatively regulates the activation of the p38 
signaling pathway in the mitogen-activated protein kinase system and consequently inhibits the release of inflam-
matory cytokines such as IL-630. Yang et al. further reported that propofol suppresses formyl peptide receptor 
1-induced human neutrophil activation via complete blockade of calcium, AKT, and ERK1/2 signaling31.
In the present study, there were no changes in serum TNF-α and CRP levels at any time point in both groups. 
Narita et al. reported no increases in TNF-α levels during laparoscopic radical prostatectomy, consistent with our 
findings, although such increases were observed during open radical prostatectomy22. Different inflammatory 
conditions result in different patterns of alteration in the levels of various stress markers32. Our results suggest 
that the TNF-α level may not be a useful marker of stress in patients undergoing laparoscopic procedures such as 
RALRP. Furthermore, no significant changes in CRP levels were observed in either group. Similarly, a previous 
study reported that CRP levels remain steady during laparoscopic surgery but increase during the postoperative 
period2. However, further studies are required to determine whether the changes observed in our study persist 
after RALRP.
There is a strong association between inflammation and oxidative stress, which interact to produce adverse 
events in several conditions. Free radicals and reactive oxygen species are risk factors for chronic inflammation 
and exhibit significantly increased expression during the inflammatory response33. Oxidative stress can by quan-
tified by measurement of various biomarkers such as NO and malondialdehyde. Immediately after ischemia, 
NO levels decrease and vasoconstriction occurs. Subsequently, after reperfusion, NO levels increase because of 
increased activity of iNOS; this can contribute to the development of problems such as renal injury and dysfunc-
tion34,35. However, in the present study, NO levels showed no significant changes at any time point, which suggests 
that renal ischemia did not occur during pneumoperitoneum, and that reperfusion injury after desufflation may 
not be strong enough to increase iNOS activity. One possible explanation for this finding is that the CO2 pressure 
was maintained at <15 mmHg during surgery; this pressure is reported to have a relatively small effect on NO 
production, although this finding remains debatable36.
Research has demonstrated that pneumoperitoneum may induce transient physiological changes in the kid-
ney, resulting in functional and structural damage associated with transient increases in creatinine values and a 
decrease in urine output37. The conventionally used CO2 pressure of 15 mmHg has been reported to decrease renal 
blood flow by 25%38. Oliguria during pneumoperitoneum can be improved by hydration, maintenance of optimal 
hemodynamic parameters, proper positioning, and administration of protective agents such as N-acetylcysteine 
or zinc. However, the protective effects of these methods remain controversial, and the mechanisms underlying 
such effects have not been determined39–41. In the present study, the intraoperative urine output was signifi-
cantly greater in patients who received propofol than in those who received desflurane, although there were no 
differences in the amount of intraoperative fluid intake and bleeding. These findings can be attributed to the 
anti-inflammatory and antioxidant effects of propofol. This theory is supported by the findings of a previous study 
involving patients undergoing mechanical ventilation, where the urine output increased in participants receiving 
propofol42,43. In an animal model of renal IRI, it was shown that propofol mitigated systemic inflammation and 
tubular damage in the kidney44. In other studies of valvular heart surgery, the incidence of acute kidney injury 
was significantly lowered in patients who received propofol than in those who received a volatile anesthetic45,46. 
Similarly, the anti-inflammatory effects of propofol, which were represented by the decreased IL-6 levels in the 
present study, may have increased the intraoperative urine output. It is also possible that these effects were due to 
the maintenance of more stable hemodynamic states during surgery under propofol anesthesia. Patients receiving 
propofol anesthesia in our study required significantly lower doses of inotropic agents, although previous studies 
have reported that propofol causes a profound decrease in the systemic blood pressure41. Another possible expla-
nation is that remifentanil, which has shown anti-inflammatory and antioxidant effects in in vitro and in vivo 
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studies47,48, may have contributed to the prevention of IRI. The amount of remifentanil infused in the propofol 
group was significantly greater than that infused in the desflurane group, and this may have increased the intra-
operative urine output. Although the renoprotective effects of remifentanil have been investigated at various 
doses, a dose of 0.1–2 mcg/kg/min was found to exhibit renoprotective effects in previous studies of IRI49–51. 
Accordingly, the doses of remifentanil used in the propofol (0.1 mcg/kg/min) and desflurane (0.07 mcg/kg/min) 
groups in the present study were somewhat lower than the effective dose affecting stress hormones and inflamma-
tory responses. Further studies should investigate this topic in detail. On the other hand, the postoperative urine 
output and creatinine levels at 24 h after surgery showed no significant differences between the two groups in the 
present study. However, this could be critical in cases of limited renal functional reserve, even if the renal blood 
flow and function return to normal after CO2 deflation41,52. In fact, recent clinical studies of major noncardiac sur-
geries have reported a close association between intraoperative oliguria and postoperative renal compromise53,54. 
Further studies are required to clarify the effects of propofol and volatile anesthesia on postoperative clinical 
outcomes in various surgical cohorts.
This study has several limitations. First, only intraoperative serological markers were analyzed. As previously 
mentioned, IRI-induced inflammatory responses may persist until 24 h after surgery2,34. In addition, postopera-
tive outcomes except those related to the kidney were not evaluated. Further studies are required to elucidate the 
effect of propofol on inflammatory responses in later postoperative stages. Second, CRP and NO levels were con-
sistently higher in the propofol group, although the differences were not statistically significant. We believe that 
an increase in the sample size could lead to statistically significant differences. However, CRP and NO levels in 
the study were mostly within the reference range, so it can be considered that the influence of pneumoperitoneum 
and anesthetic type on CRP and NO levels during RALRP are not as drastic as believed.
In conclusion, the findings of this study suggest that propofol anesthesia suppresses the inflammatory 
response during and after pneumoperitoneum and improves the intraoperative urine output in patients under-
going RALRP.
Methods
Study design. The present study was approved by the Institutional Review Board of Yonsei University 
Gangnam Severance Hospital (3-2013-0098) and registered at http://clinicaltrials.gov (NCT02149628, registered 
on May 29, 2014). Informed consent was obtained from all patients prior to their participation in the study.
Patients (age range: 20–70 years, American Society of Anesthesiologists class I or II) scheduled for RALRP 
at Yonsei University Gangnam Severance Hospital between July 2014 and July 2015 were included in this study. 
Patients with renal failure (estimated glomerular filtration rate, <60 ml/min/1.73 m2), obesity (body mass index, 
>30 kg/m2), allergies to propofol or peanuts, and/or inability to read were excluded55. The enrolled patients were 
randomly allocated (1:1) to a propofol group or a desflurane group using a randomization table prepared using a 
random sequence generator (www.random.org). All procedures and measurements were performed in accord-
ance with the relevant guidelines and regulations of our institute.
Before surgery, all patients received intravenous midazolam (0.02 mg/kg) and glycopyrrolate (0.004 mg/kg), 
following which standard monitoring devices (noninvasive blood pressure, pulse oximetry, electrocardiogra-
phy, and bispectral spectrometry) were applied. In the propofol group, anesthesia was induced with intravenous 
propofol [Schnider model with effect site concentration (Ce) of 3–4 mcg/ml] and remifentanil (Minto model 
with Ce of 3–4 ng/ml) administered via target-controlled infusion (TCI; OrchestraTM BasePrimea, FreseniusVial, 
France). In the desflurane group, anesthesia was induced with 4 mg/kg of thiopental sodium and remifent-
anil administered via TCI (Minto model with Ce of 3–4 ng/ml). When the bispectral index (BIS) decreased to 
<60, rocuronium (0.6 mg/kg) was administered prior to tracheal intubation, following which the patients were 
mechanically ventilated with a 50% oxygen-in-air mixture. The ventilator was adjusted to maintain a peak airway 
pressure of <35 cm H2O (tidal volume, 7–8 mL/kg of the ideal body weight for volume-controlled ventilation). 
The respiratory rate was adjusted to maintain an end-tidal carbon dioxide (ETCO2) pressure of 40 ± 3 mmHg. 
TCI of remifentanil (Ce of 1–5 ng/ml) was used for anesthesia maintenance in both groups, with BIS maintained 
between 40 and 60. Following the induction of anesthesia, the radial artery was cannulated for invasive blood 
pressure monitoring. Atropine (0.5 mg) was injected when the patient’s heart rate decreased to <50 beats/min. 
Hypotension was defined by a systolic blood pressure of <90 mmHg or a mean blood pressure of <60 mmHg, and 
it was treated by 4 mg of ephedrine with 200 ml of crystalloid. During the RALRP procedure, the abdominal cavity 
was insufflated with carbon dioxide (CO2) at a pressure of 15 mmHg, following which the patients were placed 
in a 30° Trendelenburg position for surgery. When the surgery neared completion, the patients were returned to 
the supine position, the abdominal cavity was deflated, and an incision measuring approximately 5 cm was placed 
for specimen removal.
Blood samples were collected through the radial arterial line at 10 min after induction (T1), 100 min after 
pneumoperitoneum (T2), and 10 min after CO2 deflation (T3). Subsequently, the samples were centrifuged 
(14,000 rpm, 15 min) and the separated serum was stored at −80 °C until analysis56.
Analysis of biomarkers. Biomarkers were assayed in the biochemical laboratory of our institution after 
study completion. An ELISA kit (Quantikine®, R&D System Inc., Minneapolis, MN, USA) was used to assess the 
levels of interleukin (IL)-6 (IL-6) and tumor necrosis factor alpha (TNF-α). The samples and reference standards 
were placed into the wells of microplates coated with monoclonal antibodies for each cytokine. The plates were 
washed to remove nonadherent materials, following which enzyme-linked polyclonal antibodies specific for each 
cytokine were added to each well. After washing for the removal of nonadherent antibody–enzyme material, 
substrate solution and amplifier solution were added for color development. After the stop solution was added, 
absorbance was measured on a plate reader (SpectraMax 190 ELISA Reader, Molecular Devices, China).
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C-reactive protein (CRP). The latex agglutination method was used for the measurement of CRP levels 
(N-Assay LA CRP-S D-TYPE, Nittobo, Japan). Latex particles saturated with anti-CRP antibody were added 
to the sample to induce aggregation of particles via antigen–antibody reactions. The change in absorbance was 
measured at a wavelength of 572 mm (Hitachi 7600-10, Hitachi, Japan), which was proportional to the concentra-
tion of CRP in the sample, which was calculated on the basis of interpolation with the standard curve.
Nitric oxide (NO). Levels of NO were determined through the measurement of nitrite levels using an ELISA 
kit (Parameter® Total Nitric Oxide and Nitrate/Nitrite Assay, R&D System Inc.). We first measured the nitrite 
concentration (X) in the sample. Subsequently, reductase was added for conversion from nitrate to nitrite, and 
the total nitrite concentration (Y) was measured. The final nitrate concentration was calculated as the differ-
ence between X and Y. Absorbance was measured on a plate reader (SpectraMax 190 ELISA Reader, Molecular 
Devices).
Study end points. The serum levels of IL-6, TNF-α, CRP, and NO were considered the primary endpoints, 
while the perioperative urine outputs and serum creatinine levels were considered secondary endpoints.
Statistical analysis. Based on a report by Ozmen et al., we determined that 25 patients per group were 
required for the detection of a 20% decrease in IL-6 levels with a power of 80% and type I error of 0.0557. SPSS 
version 18.0 (SPSS Inc., Chicago, IL, USA) was used for all statistical analyses. Variables are presented as means 
with standard deviations or numbers with percentages, as appropriate. Continuous variables were evaluated using 
Student’s t-tests or Mann–Whitney U-tests, while categorical variables were evaluated using chi-square tests or 
Fisher’s exact tests. The Bonferroni method was used for multiple comparisons. According to this method, a 
two-sided p-value of <0.0004 (=0.05/12) indicated statistical significance for the primary end points. For the 
other parameters, a two-sided p-value of <0.05 was considered statistically significant.
Data Availability
All data generated or analyzed during this study are included in this published article and its Supplementary 
Information files.
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